...
首页> 外文期刊>Journal of Lipid Research >ELOVL4 protein preferentially elongates 20:5n3 to very long chain PUFAs over 20:4n6 and 22:6n3
【24h】

ELOVL4 protein preferentially elongates 20:5n3 to very long chain PUFAs over 20:4n6 and 22:6n3

机译:ELOVL4蛋白优选在20:4n6和22:6n3上将20:5n3延长为非常长的链PUFA

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We hypothesized that reduction/loss of very long chain PUFAs (VLC-PUFAs) due to mutations in the ELOngase of very long chain fatty acid-4 (ELOVL4) protein contributes to retinal degeneration in autosomal dominant Stargardt-like macular dystrophy (STGD3) and age-related macular degeneration; hence, increasing VLC-PUFA in the retina of these patients could provide some therapeutic benefits. Thus, we tested the efficiency of elongation of C20-C22 PUFA by the ELOVL4 protein to determine which substrates are the best precursors for biosynthesis of VLCPUFA. The ELOVL4 protein was expressed in pheochromocytoma cells, while green fluorescent protein-expressing and nontransduced cells served as controls. The cells were treated with 20:5n3, 22:6n3, and 20:4n6, either individually or in equal combinations. Both transduced and control cells internalized and elongated the supplemented FAs to C22-C26 precursors. Only ELOVL4-expressing cells synthesized C28-C38 VLC-PUFA from these precursors. In general, 20:5n3 was more efficiently elongated to VLC-PUFA in the ELOVL4-expressing cells, regardless of whether it was in combination with 22:6n3 or with 20:4n6. In each FA treatment group, C34 and C36 VLC-PUFAs were the predominant VLC-PUFAs in the ELOVL4-expressing cells. In summary, 20:5n3, followed by 20:4n6, seems to be the best precursor for boosting the synthesis of VLC-PUFA by ELOVL4 protein.
机译:我们假设由于超长链脂肪酸4(ELOVL4)蛋白的ELOngase突变而导致的超长链PUFA(VLC-PUFA)的减少/丢失导致常染色体显性Stargardt样黄斑营养不良(STGD3)的视网膜变性和年龄相关性黄斑变性;因此,增加这些患者视网膜中的VLC-PUFA可以提供一些治疗益处。因此,我们测试了ELOVL4蛋白延长C20-C22 PUFA的效率,以确定哪些底物是VLCPUFA生物合成的最佳前体。 ELOVL4蛋白在嗜铬细胞瘤细胞中表达,而表达绿色荧光蛋白和未转导的细胞用作对照。分别或以相等组合用20:5n3、22:6n3和20:4n6处理细胞。转导细胞和对照细胞均内化并延长了补充的FA至C22-C26前体。仅表达ELOVL4的细胞从这些前体合成C28-C38 VLC-PUFA。通常,无论是与22:6n3还是与20:4n6结合使用,在表达ELOVL4的细胞中20:5n3都能更有效地延长至VLC-PUFA。在每个FA治疗组中,C34和C36 VLC-PUFA是表达ELOVL4的细胞中主要的VLC-PUFA。总之,20:5n3,然后是20:4n6,似乎是通过ELOVL4蛋白促进VLC-PUFA合成的最佳前体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号